{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T04:57:06Z","timestamp":1781585826477,"version":"3.54.5"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Mechanical thrombectomy (MT) has reshaped the treatment of acute ischemic stroke caused by large-vessel occlusion (LVO), yet successful angiographic reperfusion does not reliably translate into meaningful neurological recovery. Landmark randomized trials and the Highly Effective Reperfusion Evaluated in Multiple Endovascular Stroke Trials (HERMES) patient-level meta-analysis established MT as standard of care, but they also brought into focus the persistent problem of incomplete tissue-level rescue despite technically successful recanalization. Procedure-related vasospasm is usually handled as a transient intraprocedural complication, commonly with intra-arterial calcium-channel blockers, and is rarely considered within the broader biology of reperfusion failure. In this mini-review, we propose that vasospasm during endovascular thrombectomy (EVT) should be reinterpreted as a visible marker of a more complex reperfusion-failure state. This state may encompass endothelial injury, distal embolization, inflammatory leukocyte\u2013endothelial interactions,platelet-rich microthrombi, pericyte-mediated capillary constriction, and microvascular no-reflow. Within this framework, intra-arterial vasodilators warrant renewed attention not only for their ability to restore conduit vessel diameter, but also for their potential to influence the quality of tissue perfusion. This perspective is particularly relevant for phosphodiesterase-3 (PDE3) inhibitors such as milrinone, whose pharmacological profile combines vasodilatory effects with biologically demonstrable modulation of platelet activity. Beyond conduit vessel relaxation, such agents may act at the interface between macrovascular recanalization and microvascular reperfusion. We propose that procedure-related vasospasm may identify a subgroup of patients in whom successful recanalization fails to secure effective microvascular reperfusion, and that future studies should evaluate vasodilator strategies using endpoints that extend beyond angiographic resolution to include tissue perfusion, infarct evolution, and functional outcome.<\/jats:p>","DOI":"10.3389\/fneur.2026.1842242","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T04:29:40Z","timestamp":1781584180000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Procedure-related vasospasm and reperfusion vulnerability during mechanical thrombectomy"],"prefix":"10.3389","volume":"17","author":[{"given":"Tarek","family":"El Halabi","sequence":"first","affiliation":[{"name":"Department of Neurology, American University of Beirut Medical Center","place":["Beirut, Lebanon"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rim","family":"Araoui","sequence":"additional","affiliation":[{"name":"Department of Neurology, American University of Beirut Medical Center","place":["Beirut, Lebanon"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1056\/NEJMoa1414905","article-title":"Randomized assessment of rapid endovascular treatment of ischemic stroke","volume":"372","author":"Goyal","year":"2015","journal-title":"N Engl J Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1056\/NEJMoa1415061","article-title":"Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke","volume":"372","author":"Saver","year":"2015","journal-title":"N Engl J Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1056\/NEJMoa1414792","article-title":"Endovascular therapy for ischemic stroke with perfusion-imaging selection","volume":"372","author":"Campbell","year":"2015","journal-title":"N Engl J Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/S0140-6736(16)00163-X","article-title":"Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials","volume":"387","author":"Goyal","year":"2016","journal-title":"Lancet."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1161\/STROKEAHA.113.001972","article-title":"Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement","volume":"44","author":"Zaidat","year":"2013","journal-title":"Stroke."},{"key":"B6","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1177\/0271678X20954929","article-title":"Tissue no-reflow despite full recanalization following thrombectomy for anterior circulation stroke with proximal occlusion: a clinical study","volume":"41","author":"Ter Schiphorst","year":"2021","journal-title":"J Cereb Blood Flow Metab."},{"key":"B7","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1161\/STROKEAHA.122.038466","article-title":"Clinically ineffective reperfusion after endovascular therapy in acute ischemic stroke","volume":"54","author":"Nie","year":"2023","journal-title":"Stroke."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1161\/STROKEAHA.123.044240","article-title":"No-reflow post-recanalization in acute ischemic stroke: mechanisms, measurements, and molecular markers","volume":"54","author":"Sperring","year":"2023","journal-title":"Stroke."},{"key":"B9","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1177\/17474930231180434","article-title":"No-reflow phenomenon in stroke patients: a systematic literature review and meta-analysis of clinical data","volume":"19","author":"Mujanovic","year":"2024","journal-title":"Int J Stroke."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e14631","DOI":"10.1111\/cns.14631","article-title":"No-reflow after stroke reperfusion therapy: an emerging phenomenon to be explored","volume":"30","author":"Jia","year":"2024","journal-title":"CNS Neurosci Ther."},{"key":"B11","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1136\/neurintsurg-2014-011491","article-title":"Risk of distal embolization with stent retriever thrombectomy and ADAPT","volume":"8","author":"Chueh","year":"2016","journal-title":"J Neurointerv Surg."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1161\/STROKEAHA.118.021320","article-title":"Number of stent retriever passes associated with futile recanalization in acute stroke","volume":"49","author":"Baek","year":"2018","journal-title":"Stroke."},{"key":"B13","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1177\/1747493017743051","article-title":"Complications of endovascular treatment for acute ischemic stroke: prevention and management","volume":"13","author":"Balami","year":"2018","journal-title":"Int J Stroke."},{"key":"B14","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s00234-014-1352-0","article-title":"Complications of mechanical thrombectomy for acute ischemic stroke-a retrospective single-center study of 176 consecutive cases","volume":"56","author":"Behme","year":"2014","journal-title":"Neuroradiology."},{"key":"B15","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1177\/23969873231177766","article-title":"Prediction and outcomes of cerebral vasospasm in ischemic stroke patients receiving anterior circulation endovascular stroke treatment","volume":"8","author":"Jesser","year":"2023","journal-title":"Eur Stroke J."},{"key":"B16","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12883-022-03045-x","article-title":"Effect of intra-arterial nimodipine on iatrogenic vasospasms during endovascular stroke treatment\u2014angiographic resolution and infarct growth in follow-up imaging","volume":"23","author":"Jesser","year":"2023","journal-title":"BMC Neurol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1136\/svn-2023-002788","article-title":"Treatment practice of vasospasm during endovascular thrombectomy: an international survey","volume":"9","author":"Jesser","year":"2024","journal-title":"Stroke Vasc Neurol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s00062-024-01424-0","article-title":"Nimodipine as vasodilator in guide catheter flush to prevent vasospasm during endovascular stroke treatment","volume":"34","author":"Sommer","year":"2024","journal-title":"Clin Neuroradiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e16467","DOI":"10.1111\/ene.16467","article-title":"Iatrogenic arterial vasospasm during mechanical thrombectomy requiring treatment with intra-arterial nimodipine might be associated with worse outcomes","volume":"31","author":"Ferhat","year":"2024","journal-title":"Eur J Neurol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"E20","DOI":"10.3171\/2017.1.FOCUS16492","article-title":"Vessel wall signal enhancement on 3-T MRI in acute stroke patients after stent retriever thrombectomy","volume":"42","author":"Abraham","year":"2017","journal-title":"Neurosurg Focus."},{"key":"B21","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1161\/01.STR.23.5.712","article-title":"Inhibition of polymorphonuclear leukocyte adherence suppresses no-reflow after focal cerebral ischemia in baboons Stroke","volume":"23","author":"Mori","year":"1992"},{"key":"B22","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1001\/jama.2022.7430","article-title":"Effect of intra-arterial alteplase vs placebo following successful thrombectomy on functional outcomes in patients with large vessel occlusion acute ischemic stroke: the CHOICE randomized clinical trial","volume":"327","author":"Chamorro","year":"2022","journal-title":"JAMA."},{"key":"B23","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1161\/01.STR.25.1.202","article-title":"P-selectin and intercellular adhesion molecule-1 expression after focal brain ischemia and reperfusion","volume":"25","author":"Okada","year":"1994","journal-title":"Stroke"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awad401","article-title":"Continued dysfunction of capillary pericytes promotes no-reflow after experimental stroke in vivo","author":"Shrouder","year":"2024","journal-title":"Brain"},{"key":"B25","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.expneurol.2011.11.038","article-title":"Cilostazol, a phosphodiesterase inhibitor, prevents no-reflow and hemorrhage in mice with focal cerebral ischemia","volume":"233","author":"Hase","year":"2012","journal-title":"Exp Neurol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0049-3848(93)90097-8","article-title":"Effect of milrinone in human platelet shape change, aggregation and thromboxane A2 synthesis: an in vitro study","volume":"71","author":"Barradas","year":"1993","journal-title":"Thromb Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1053\/j.jvca.2005.11.007","article-title":"Phosphodiesterase III inhibition affects platelet-monocyte aggregate formation depending on the axis of stimulation","volume":"20","author":"Horn","year":"2006","journal-title":"J Cardiothorac Vasc Anesth."},{"key":"B28","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1161\/STROKEAHA.107.492447","article-title":"Milrinone for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage","volume":"39","author":"Fraticelli","year":"2008","journal-title":"Stroke."},{"key":"B29","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/s12028-012-9701-5","article-title":"Milrinone and homeostasis to treat cerebral vasospasm associated with subarachnoid hemorrhage: the Montreal Neurological Hospital protocol","volume":"16","author":"Lannes","year":"2012","journal-title":"Neurocrit Care"},{"key":"B30","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s12028-021-01331-z","article-title":"Intravenous milrinone for cerebral vasospasm in subarachnoid hemorrhage: the MILRISPASM controlled before-after study","volume":"35","author":"Lakhal","year":"2021","journal-title":"Neurocrit Care."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1227\/00006123-200104000-00004","article-title":"Milrinone for the treatment of cerebral vasospasm after subarachnoid hemorrhage: report of seven cases","author":"Arakawa","year":"2001","journal-title":"Neurosurgery"},{"key":"B32","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1177\/1074248418797357","article-title":"Comparative effectiveness and safety between milrinone or dobutamine as initial inotrope therapy in cardiogenic shock","volume":"24","author":"Lewis","year":"2019","journal-title":"J Cardiovasc Pharmacol Ther."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1842242\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T04:29:41Z","timestamp":1781584181000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1842242\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":32,"alternative-id":["10.3389\/fneur.2026.1842242"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2026.1842242","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]},"article-number":"1842242"}}